Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
NCT07455734
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
533
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor Cancer
Interventions
DRUG:
BNT3214
Sponsor
BioNTech SE
Collaborators
[object Object]
[object Object]